Search

Ganfeng Cao

from Shawnee on Delaware, PA
Age ~53
Get Report
Also known as:
Gan F Cao, Gansen Cao, Cao Ganfeng, G Cao, Cao Gan
Related to:
Cao Youfu, 47Jerry CaoGangfeng CaoDansing CaoGary Cao
Connected to:
Alain A Cao, 39Alex T Cao, 51Alexandra H Cao, 35Anne M Cao, 49Annie N Cao, 50Ben T Cao, 55Cam D Cao, 70Carol A Cao, 45Chen Cao, 51Chieu X Cao, 61

Ganfeng Cao Phones & Addresses

  • Shawnee on Delaware, PA
  • Myrtle Beach, SC
  • 119 Clear Creek Dr, Bear, DE 19701 (302) 832-2754
  • Conway, SC
  • Brasher Falls, NY
  • Chadds Ford, PA
  • Davenport, FL
  • Ann Arbor, MI
  • Newark, DE

Publications

Us Patents

3-Aminocyclopentanecarboxamides As Modulators Of Chemokine Receptors

View page
US Patent:
7449467, Nov 11, 2008
Filed:
Jun 27, 2005
Appl. No.:
11/167816
Inventors:
Changsheng Zheng - Wilmington DE, US
Hao Feng - Aston PA, US
Michael Xia - Hockessin DE, US
Joseph Glenn - Sicklerville NJ, US
Ganfeng Cao - Newark DE, US
Brian W. Metcalf - Moraga CA, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K 31/497
A61K 31/445
C07D 403/12
C07D 241/04
C07D 211/02
US Classification:
51425301, 51425411, 514318, 544295, 544358, 544360, 546194
Abstract:
The present invention is directed to compounds of Formula I:.

Purinone Derivatives As Hm74A Agonists

View page
US Patent:
7462624, Dec 9, 2008
Filed:
Jun 22, 2007
Appl. No.:
11/766990
Inventors:
Brian Metcalf - Moraga CA, US
Anlai Wang - Wilmington DE, US
Changsheng Zheng - Wilmington DE, US
Ganfeng Cao - Bear DE, US
Ke Zhang - Wilmington DE, US
Assignee:
Incyte Corporation - Wilmington DE
International Classification:
A01N 43/54
A61K 31/505
C07D 239/00
C07D 471/00
C07D 487/00
C07D 491/00
US Classification:
514267, 544251
Abstract:
The present invention relates to purinone derivatives which are agonists of the HM74a receptor. Further provided are compositions and methods of using the compounds herein, and their pharmaceutically acceptable salts for the treatment of disease.

Purinone Derivatives As Hm74A Agonists

View page
US Patent:
7511050, Mar 31, 2009
Filed:
Jun 22, 2007
Appl. No.:
11/766981
Inventors:
Changsheng Zheng - Wilmington DE, US
Ganfeng Cao - Bear DE, US
Michael Xia - Wilmington DE, US
Anlai Wang - Wilmington DE, US
Hai Fen Ye - Newark DE, US
Brian Metcalf - Moraga CA, US
Assignee:
Incyte Corporation - Wilmington DE
International Classification:
A01N 43/54
A61K 31/505
C07D 239/00
C07D 471/00
C07D 487/00
C07D 491/00
US Classification:
514267, 544251
Abstract:
The present invention relates to purinone derivatives which are agonists of the HM74a receptor. Further provided are compositions and methods of using the compounds herein, and their pharmaceutically acceptable salts for the treatment of disease.

3-Aminocyclopentanecarboxamides As Modulators Of Chemokine Receptors

View page
US Patent:
7618970, Nov 17, 2009
Filed:
Jun 27, 2005
Appl. No.:
11/167329
Inventors:
Changsheng Zheng - Wilmington DE, US
Hao Feng - Aston PA, US
Michael Xia - Hockessin DE, US
Joseph Glenn - Sicklerville NJ, US
Ganfeng Cao - Newark DE, US
Brian W. Metcalf - Moraga CA, US
Assignee:
Incyte Corporation - Wilmington DE
International Classification:
A61K 31/497
A61K 31/445
C07D 403/08
C07D 295/23
C07D 401/08
US Classification:
51425301, 51425411, 514318, 544295, 544358, 544360, 546194
Abstract:
The present invention is directed to compounds of Formula I:.

Piperazinylpiperidine Derivatives As Chemokine Receptor Antagonists

View page
US Patent:
7678798, Mar 16, 2010
Filed:
Apr 12, 2005
Appl. No.:
11/104041
Inventors:
Ganfeng Cao - Bear DE, US
Taisheng Huang - Wilmington DE, US
Lihua Chen - Boothwyn PA, US
Ke Zhang - Wilmington DE, US
Anlai Wang - Wilmington DE, US
David Meloni - Bear DE, US
Rajan Anand - Wilmington DE, US
Joseph Glenn - Sicklerville NJ, US
Brian W. Metcalf - Moraga CA, US
Assignee:
Incyte Corporation - Wilmington DE
International Classification:
A61K 31/497
C07D 247/02
A61K 31/496
A61P 29/00
C07D 237/28
C07D 487/00
C07D 401/04
C07D 403/04
C07D 405/04
C07D 409/04
C07D 411/04
C07D 413/04
C07D 417/04
C07D 419/04
C07D 241/04
C07D 277/22
C07D 307/78
C07D 303/08
C07C 49/297
C07C 33/46
US Classification:
51425218, 544295, 544336, 544363, 544235, 544360, 548110, 549546, 549467, 568 52, 568812, 568327, 568425, 585 24, 546170
Abstract:
The present invention relates to compounds of Formula I:.

Purinone Derivatives As Hm74A Agonists

View page
US Patent:
7863285, Jan 4, 2011
Filed:
Sep 25, 2008
Appl. No.:
12/237807
Inventors:
Brian Metcalf - Moraga CA, US
Anlai Wang - Wilmington DE, US
Changsheng Zheng - Wilmington DE, US
Ganfeng Cao - Bear DE, US
Ke Zhang - Wilmington DE, US
Assignee:
Incyte Corporation - Wilmington DE
International Classification:
A61K 31/505
US Classification:
514267
Abstract:
The present invention relates to purinone derivatives which are agonists of the HM74a receptor. Further provided are compositions and methods of using the compounds herein, and their pharmaceutically acceptable salts for the treatment of disease.

Purinone Derivatives As Hm74A Agonists

View page
US Patent:
7902205, Mar 8, 2011
Filed:
Sep 25, 2008
Appl. No.:
12/237794
Inventors:
Brian Metcalf - Moraga CA, US
Anlai Wang - Wilmington DE, US
Changsheng Zheng - Wilmington DE, US
Ganfeng Cao - Bear DE, US
Ke Zhang - Wilmington DE, US
Assignee:
Incyte Corporation - Wilmington DE
International Classification:
A01N 43/54
A61K 31/505
C07D 491/00
US Classification:
514267, 544251
Abstract:
The present invention relates to purinone derivatives which are agonists of the HM74a receptor. Further provided are compositions and methods of using the compounds herein, and their pharmaceutically acceptable salts for the treatment of disease.

Purinone Derivatives As Hm74A Agonists

View page
US Patent:
8039478, Oct 18, 2011
Filed:
Nov 3, 2008
Appl. No.:
12/263990
Inventors:
Changsheng Zheng - Wilmington DE, US
Ganfeng Cao - Bear DE, US
Michael Xia - Wilmington DE, US
Anlai Wang - Wilmington DE, US
Hai Fen Ye - Newark DE, US
Brian Metcalf - Moraga CA, US
Assignee:
Incyte Corporation - Wilmington DE
International Classification:
A01N 43/54
A61K 31/505
C07D 239/00
C07D 487/00
US Classification:
514267, 544251
Abstract:
The present invention relates to purinone derivatives which are agonists of the HM74a receptor. Further provided are compositions and methods of using the compounds herein, and their pharmaceutically acceptable salts for the treatment of disease.
Control profile
Ganfeng Cao from Shawnee on Delaware, PA, age ~53 Get Report